NCT07188662

Brief Summary

The goal of this clinical trial is to evaluate the role of multimodal Prehabilitation program on improve surgical outcomes after gynecological oncology surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 23, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 23, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 11, 2025

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 23, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 23, 2025

Completed
Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

July 11, 2025

Last Update Submit

September 19, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • changing the postoperative morbidity

    compare the 30 days postoperative morbidity of the prehabilitation and conventional group, it included (Assess the post-operative complications by using Clavien-Dindo classification; from Grade I-IV; higher grades indicate more severe complications.)

    "up to 30 days postoperative"

  • changing the postoperative mortality

    compare the 30 days postoperative mortality of the prehabilitation group and conventional group.

    "up to 30 days postoperative"

  • Pain intensity measured by the Visual Analog Scale (VAS) for pain.

    compare the 30 days postoperative Pain intensity; Unit of Measure: Units on a scale (0-10 cm). Scale: 0 = no pain, 10 = worst pain imaginable; higher scores indicate worse pain of the prehabilitation group and conventional group.

    "up to 30 days postoperative"

Secondary Outcomes (9)

  • change the length of the hospital stay

    up to 5 days post-operative

  • Enhance the physical state of gynecological oncology patient using the Eastern Cooperative Oncology Group (ECOG)

    through the postoperative period within two hours up-to 30 days after surgery

  • Enhance the psychological wellbeing of gynecological oncology patient

    up-to 15 days preoperatively & up to 30 days post operatively]

  • assess and changing the Nutritional Status of the prehabilitation group

    up-to 30 days postoperative

  • assess and changing the Nutritional Status of the prehabilitation group

    up-to 30 days postoperative

  • +4 more secondary outcomes

Study Arms (2)

Conventional group

NO INTERVENTION

Conventional group (woman received hospital care at previous year as a retrospective sample to prevent risk of bias) equal 70 woman

Prehabilitation group

EXPERIMENTAL

Prehabilitation group (woman who will receive prehabilitation care combine with ERAS post-operative care as a prospective sample) equal 70 woman

Procedure: group (B) Prehabilitation care combine with ERAS post-operative care

Interventions

intervention will includes receiving prehabilitation care combine with ERAS post-operative care.

Prehabilitation group

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Newly diagnosed woman with gynecologic cancer by imaging \&histopathology
  • Accept participation in the study.

You may not qualify if:

  • Patient with advanced and metastatic stage
  • Patient who received neoadjuvant chemotherapy
  • Patient who have psychological disorder such as suicidal attempt
  • Patient who have cerebral stroke, hemiplegia or paralyses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Woman's Health Hospital

Asyut, Egypt

Location

MeSH Terms

Interventions

Population Groups

Intervention Hierarchy (Ancestors)

DemographyPopulation Characteristics

Study Officials

  • Aziza M Mohammed, Head nurse

    Woman's Health Hospital, Assiut University, Egypt

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of maternity, gynecological and obstetric nursing

Study Record Dates

First Submitted

July 11, 2025

First Posted

September 23, 2025

Study Start

April 23, 2024

Primary Completion

April 23, 2025

Study Completion

July 23, 2025

Last Updated

September 23, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations